Member Info for unhooked

I have them in my HL ISA. I also have an ISA with Barclays and, it's true, GRID doesn't seem to be available there. Has to be said, Barclays doesn't have as wide a selection as HL.... no USA shares on Barclays, for instance.

Brave of you, SB, to go for that 9p offer - I've tended to trade my VRCI shares, only buying when there's a large spike down (which has happened regularly enough!), and that's proved a generally successful strategy for me. However, to be clear, of the 3 Harwood biotechs I've placed most of my chips on RENX....which (of course) has been the worst performer. Honestly, I'd take an 80% dilution if it meant we were properly funded (for at least 18 months), because I think that sort of outcome is baked into a 11p share price.

Hi Hawker, welcome back... to the dark side!

In the wake of the Thermo Fischer deal, I see Verici have announced a placing this morning at an 11% discount to yesterday's price. It would be well done if RENX could get a meaningful fundraise off at a similar discount, but we don't have an equivalent partnership here.

Good grief, article posted and quoted from is more than 30 months old! Wicher Kist has long since lost the job of CEO.

Thank you pony4sale. EBITDA loss is one thing but does anyone have a figure for the actual cash burn over the past 12 months? I feel that is the more salient number.

More management changes are the last thing we need - indeed it's the revolving door of management teams with no skin in the game that has gotten Synthomer into trouble in the fist place, in my opinion. Remember, this lot are not responsible for the disastrous Eastman acquisition, which piled on the debt.... that was the last lot and they've long since scarpered.

Peregrinetrouser, firstly, if you're in your 9th decade then congratulations are in order! Secondly, I didn't mean to presume and at your ripe old age I'm sure you know what you're doing and are allowed a few speculative punts. However, I slightly disagree when you say it's early days to judge - at least in some cases he's been ramping them for quite a while during which time they've fallen precipitously... anyway, each to their own and their own risk-tolerances. Good luck.

TheTrotsky, Saietta is in a perilous state. I've mentally written off what's left of my investment. It may come good but it would need to massively multibag for me to get my money back. Very high risk.

peregrinetrouser, I worry when you say that because you bought Saietta before reading the Oak Bloke's analysis, it was your fault for doing so. Firstly it doesn't make sense because the Oak Bloke is bullish on Saietta and would have encouraged you to buy more had you read it. Secondly, whether you read his tip or not, it is *always* your fault when you commit your own money to an investment. That's why you see DYOR (do your own research) after everything, as I'm sure you know, and, indeed, why the oak bloke says his analysis is 'for entertainment value only'. peregrinetrouser, you say you're in several of the companies he's covers and he can do no wrong. Ask yourself how will you feel if these investments go bad? Will you blame yourself or him? You should be blaming yourself of course. The Oak Bloke's interested in v high risk parts of the market and I ask again have any of his investments actually come good? It's not for me to get involved in your choices, but respectfully I say be very careful... and position size according to the risk.

I'm not sure about the Oak Bloke. His analysis reads well but when you look at his picks there's no doubt he's fishing in the high risk end. I'm also in Saietta, one of his 'Growth Ideas' and it has not gone well. Looking at his picks below, has he actually had a win?

https://theoakbloke.substack.com/p/happy-christmas-reader

....in a convoluted notification.

Decision 'expected in calendar year 2024'... I think.

And sales? Where's that RNS??

The 28% dividend doesn't look attractive if the capital value declines twice as fast...

Caught a falling knife.

Wow, 127p to buy. Capitulation!

Nope. When I first invested here I remember thinking the cash position gave a long runway, but I hadn't anticipated the very high burn rate. I've noticed quite a few low quality company managements (often found on AIM) operating their businesses profligately, and continuing to do so well after the era of free money ended. We were told one of the advantages of small caps is that they are 'nimble' and 'quick to adapt' to changing conditions. Hmm, not this lot! So much nicer to spend money, be generous, dole out jobs to friends and colleagues; so much harder to cut spending, be mean and axe jobs, but there are times when this is required or better still anticipated by smart managers.

A final unpalatable thought is that the tech may, in the end, be rubbish. You'd have thought if the IP had medical, let alone commercial, significance, the company would have got its funding or been bought out by a trade buyer (e.g. a Pfizer) long ago. That it hasn't probably speaks volumes.

A total mockery, SB! It almost feels like a scam... I hate to use that word in relation to the stock market because it diminishes my own culpability for the investment decision (as in 'not my fault, I've been scammed') and I would not want to do that, but it does feel like I've fallen for a confidence trick... What were the IPO/placings investors thinking when they ponied up the money and what exactly were they told by RENX management? Exactly why are sales non-existent? Is it the ultimate plan for Mt. Sinai, the management & other partners to obtain the tech cheaply by letting the company go to the wall, having rinsed UK AIM investors? Feels like it.

Mike I was just wondering if there was some sort of conversion process if the euro and GBP shares had different values, but probably over complicating things. If not, then you're quite right, the number of shares will stay the same but simply be expressed in euros. The key point I was making (and make again now) is that the overall value of the holding, in whichever currency it's expressed in, will be the same from one day to the next, and there really is nothing to worry about here.

With a misleading thread title like "Delisting of Tui", it's not surprising inexperienced UK investors are getting stressed.

Let's be clear, Tui is not delisting. It will remain listed in Germany, its main market, throughout the process of delisting from AIM.

So what will happen that's so scary? Not much. One morning I'll wake up and look at my HL account, and instead of seeing my Tui shares denominated in sterling, they will be denominated in euros (for this reason, the number of shares held will change slightly - the point being that the total value, whether in euros or pounds, should be about the same as the the day before). Now if I want to sell them (or buy more) HL will give me a live quote, just as they do now. The only difference I will see will be a 1% foreign exchange fee which HL charges on the buying & selling of foreign shares. If you take a medium term view on these shares, as I do, a 1% charge is neither here nor there.

I'm still disappointed to see the sp fall since the announcement - I'm thinking some of the reason will be institutional investors who are mandated only to hold UK listed shares, selling out.

Personally, I'm pretty relaxed about this mis-labelling 'scandal'. It's also a shame that they are considering the closure of their only UK manufacturing facility in Leicestershire, which they only opened 2 years ago, however these things are linked.

The spectre of competing with Shein is the common issue here. If the govt won't level the playing field, then I won't blame Boohoo for trying to do so. Fast fashion is cut-throat and holding one's nose is an unavoidable part of investing here.

RNS this morning - more favourable data for KidneyIntelX. Great news!

Share price unaffected of course. You can have all the health authority coverage, all the permissions, all the favourable data that you can shake a fist at, but without sales it means zilch. Sometimes one feels the BOD are living in a parallel universe with these RNSs.... all this wonderful data while the share price declines 98% (which they never mention) and the co. is close to going bust. Hello? BOD? Wakey-wakey!?

Yup, they go up the stairs and down the proverbial elevator. Plus ca change!

Much obliged gents.